Ligand validation:6HLA

MPO: 3[N-MORPHOLINO]PROPANE SULFONIC ACID

MPO is a Ligand Of Interest in 6HLA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HLA_MPO_D_505	23%	60%	0.198	0.821	1.08	0.44	1	-	0	0	100%	1
6HLA_MPO_B_505	6%	53%	0.25	0.691	1.38	0.47	1	-	0	0	100%	1
6HLJ_MPO_D_504	72%	57%	0.114	0.938	1.29	0.37	1	-	0	0	100%	1
6HLM_MPO_B_505	63%	39%	0.131	0.928	1.86	0.63	1	-	0	0	100%	0.7
6HL3_MPO_D_505	36%	55%	0.169	0.861	1.45	0.31	1	-	0	0	100%	1
8QG1_MPO_D_504	31%	47%	0.156	0.921	1.14	0.91	1	-	0	0	46%	0.4615
4MZC_MPO_A_201	100%	62%	0.031	0.998	0.43	0.98	-	1	0	0	100%	1
1KJQ_MPO_A_397	100%	28%	0.042	0.99	1.69	1.37	2	2	0	0	100%	1
1KJ9_MPO_A_400	100%	21%	0.046	0.988	2.1	1.42	2	3	0	0	100%	1
1KJI_MPO_A_398	99%	18%	0.052	0.989	1.99	1.7	2	3	0	0	100%	1
4LRQ_MPO_B_201	99%	10%	0.061	0.99	2.22	2.32	2	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.